ASPH and Hypokalemia: For the latter, disease-causing somatic mutations have been identified in the KCNJ5 (48), CACNA1D (49), ATP1A1 or ATP2B3 genes (50), which are clinically associated with a more severe phenotype and a higher prevalence of hypokalemia than in BAH (1).